Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative chlorhexidine after lower impacted third molar removal
NL-OMON54943Phase 4Completed
- Sponsor
- Isala
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine in alveolar osteitis (AO) (2 arms), sponsored by Isala. Primary endpoint: Postoperative complications after lower third molar removal. Started Jul 2021; status: completed.
02
Drugs
chlorhexidine
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NL-OMON54943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54943.